Discovery of potent and selective epidermal growth factor receptor (EGFR) bifunctional small-molecule degraders

M Cheng, X Yu, K Lu, L Xie, L Wang… - Journal of medicinal …, 2020 - ACS Publications
Several epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been
developed and approved by Food and Drug Administration for the treatment of non-small …
被引用次数：129 相关文章
[HTML] nih.gov

[HTML][HTML] Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders

M Cheng, X Yu, K Lu, L Xie, L Wang… - Journal of medicinal …, 2020 - ncbi.nlm.nih.gov
Several epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been
developed and approved by Food and Drug Administration for the treatment of non-small …

Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders

M Cheng, X Yu, K Lu, L Xie, L Wang… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Several epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been
developed and approved by Food and Drug Administration for the treatment of non-small …

Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders.

M Cheng, X Yu, K Lu, L Xie, L Wang… - Journal of Medicinal …, 2020 - europepmc.org
Several epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been
developed and approved by Food and Drug Administration for the treatment of non-small …

Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders.

M Cheng, X Yu, K Lu, L Xie, L Wang… - Journal of Medicinal …, 2020 - europepmc.org
Several epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been
developed and approved by Food and Drug Administration for the treatment of non-small …